ArticleJAMA network open2024

Overall Survival, Treatment Duration, and Rechallenge Outcomes With ICI Therapy for Recurrent or Metastatic HNSCC.

Lova Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.